Aspira Pathlab Reports Strong Q4 Growth with 194% Increase in Profit After Tax
Aspira Pathlab & Diagnostics has announced its financial results for the quarter ending December 2024, revealing a significant increase in Profit After Tax (PAT) to Rs 1.37 crore, up 194.48% year-on-year. Net sales for the half-year reached Rs 11.59 crore, reflecting a 70.94% growth, indicating strong operational performance.
Aspira Pathlab & Diagnostics has recently reported its financial results for the quarter ending December 2024, showcasing notable developments in its performance metrics. The company, operating within the Hospital & Healthcare Services industry, has experienced a positive shift in its evaluation, with its score reflecting an adjustment from 16 to 18 over the past three months.The financial results indicate a significant growth in Profit After Tax (PAT), which reached Rs 1.37 crore, marking a year-on-year increase of 194.48%. This substantial growth in PAT highlights a strong upward trend in profitability for the company. Additionally, net sales for the half-year period amounted to Rs 11.59 crore, demonstrating a year-on-year growth of 70.94%. This performance suggests a robust sales trajectory in the near term.
Furthermore, the PAT for the half-year period has surpassed the total for the preceding twelve months, indicating a positive shift in the company's financial health. Overall, Aspira Pathlab's recent financial results reflect a favorable trend in its operational performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
